Conmed Corp logo

Conmed Corp

1
NYSE:CNMD (USA)   Ordinary Shares
$ 75.47 +0.925 (+1.24%) 03:45 PM EST
29.07
P/B:
2.73
Volume:
541.39K
Avg Vol (2M):
575.50K
Also Trade In:
Volume:
541.39K
Avg Vol (2M):
575.50K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for CNMD ( Conmed Corp ) from 1990 to May 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Conmed stock (CNMD) PE ratio as of May 16 2024 is 29.07. More Details

Conmed Corp (CNMD) PE Ratio (TTM) Chart

To

Conmed Corp (CNMD) PE Ratio (TTM) Historical Data

Total 1230
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Conmed PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-16 28.9 2024-03-13 42.0
2024-05-15 28.6 2024-03-12 41.6
2024-05-14 27.8 2024-03-11 41.6
2024-05-13 27.9 2024-03-08 41.7
2024-05-10 27.3 2024-03-07 41.7
2024-05-09 26.9 2024-03-06 41.5
2024-05-08 26.6 2024-03-05 40.8
2024-05-07 27.4 2024-03-04 40.6
2024-05-06 27.1 2024-03-01 39.2
2024-05-03 27.5 2024-02-29 39.4
2024-05-02 26.9 2024-02-28 39.0
2024-05-01 26.2 2024-02-27 39.5
2024-04-30 26.1 2024-02-26 39.3
2024-04-29 25.8 2024-02-23 39.6
2024-04-26 25.2 2024-02-22 39.9
2024-04-25 23.7 2024-02-21 40.0
2024-04-24 26.8 2024-02-20 39.8
2024-04-23 27.3 2024-02-16 39.7
2024-04-22 27.8 2024-02-15 41.1
2024-04-19 27.8 2024-02-14 40.7
2024-04-18 27.2 2024-02-13 41.4
2024-04-17 27.9 2024-02-12 43.0
2024-04-16 29.7 2024-02-09 42.6
2024-04-15 28.8 2024-02-08 41.4
2024-04-12 28.6 2024-02-07 40.9
2024-04-11 29.1 2024-02-06 40.9
2024-04-10 30.5 2024-02-05 40.4
2024-04-09 30.8 2024-02-02 39.7
2024-04-08 30.1 2024-02-01 41.1
2024-04-05 29.9 2024-01-31 46.9
2024-04-04 29.8 2024-01-30 46.5
2024-04-03 29.9 2024-01-29 46.5
2024-04-02 29.7 2024-01-26 45.1
2024-04-01 30.3 2024-01-25 46.0
2024-03-28 30.7 2024-01-24 44.6
2024-03-27 39.3 2024-01-23 48.2
2024-03-26 37.8 2024-01-22 49.0
2024-03-25 37.6 2024-01-19 49.9
2024-03-22 37.1 2024-01-18 50.8
2024-03-21 36.9 2024-01-17 53.7
2024-03-20 37.3 2024-01-16 54.2
2024-03-19 37.4 2024-01-12 54.7
2024-03-18 37.5 2024-01-11 54.9
2024-03-15 38.0 2024-01-10 55.1
2024-03-14 38.6 2024-01-09 55.0

Conmed Corp (CNMD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Conmed Corp logo
Conmed Corp
NAICS : 334510 SIC : 3845
ISIN : US2074101013

Share Class Description:

CNMD: Ordinary Shares
Description
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.